Dr Neville Kukreja: Consultant Cardiologist, Hertfordshire & North London

Dr Neville Kukreja is a Consultant Interventional Cardiologist at the East and North Hertfordshire NHS Trust and the Royal Brompton and Harefield NHS Trust. He is a recognised international expert in Interventional Cardiology (angioplasty and stenting) who has been an invited speaker at prestigious meetings throughout Europe and the USA. He has also been an invited lecturer at the Royal College of Physicians.

Dr. Kukreja undertook undergraduate studies in Cambridge and London before completing his general medical and cardiology training in London. He underwent training in Interventional Cardiology at St Mary’s Hospital and the Royal Brompton Hospital in London and also at the world-famous Thoraxcenter in Rotterdam.

Dr. Kukreja currently contributes towards the general and interventional cardiology service in East & North Hertfordshire, including the provision of daytime primary percutaneous coronary intervention for local patients suffering a heart attack. He also participates in the on call rota at the Harefield Heart Attack Centre, one of the busiest units in the country providing 24hr emergency treatment for patients from Northwest London, Hertfordshire and Bedfordshire.

Professional memberships

• Royal College of Physicians (London)

• British Cardiovascular Society

• British Cardiovascular Intervention Society

• European Society of Cardiology

• European Association of Percutaneous Coronary Intervention

Clinical interests in cardiology

General adult cardiology with particular expertise in all aspects of percutaneous coronary intervention (angioplasty and stent) and multi-slice CT angiography.

Research

Dr. Kukreja's main research interests are the evaluation of new and existing drug-eluting stents and invasive coronary imaging (intravascular ultrasound and optical coherence tomography).

He has co-authored more than 40 original research articles, 10 review articles and 5 book chapters. He has also been a co-author of more than 45 scientific abstracts which he has presented at major national and international cardiology scientific meetings.

Research publications

• Sharma S, Kukreja N, Christopoulos C, Gorog DA. Drug-eluting balloon new tool in the box. Expert Rev Med Devices. 2010 May;7(3):381-8.

• Onuma Y, Serruys PW, Kukreja N et al. Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials. Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials. Eur Heart J. 2010 May;31(9):1071-8.

• Tyczynski P, Ferrante G, Kukreja N, Moreno-Ambroj C, Barlis P, Ramasami N, De Silva R, Beatt K, Di Mario C. Optical coherence tomography assessment of a new dedicated bifurcation stent. EuroIntervention. 2009 Nov;5(5):544-51.

• Onuma Y, Kukreja N, Piazza N et al. The Everolimus-Eluting Stent in Real-World Patients: Six-Month Follow-Up of the Xience V Stent Evaluated at Rotterdam Cardiac Hospital (X-SEARCH) Registry. J Am Coll Cardiol. 2009 Jul 14;54(3):269-76.

• Kukreja N, Serruys PW, de Bruyne B et al. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II). Heart. 2009 Jul;95(13):1061-6.

• Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW on behalf of the interventional cardiologists of the Thoraxcenter (2000-5). The risk of stent thrombosis in patients with acute coronary syndromes treated with bare metal and drug-eluting stents. JACC Cardiovasc Interv. 2009 Jun;2(6):534-41.

• Kukreja N, Onuma Y, Serruys PW. The Xience V everolimus-eluting coronary stent. Expert Rev Med Devices. 2009 May;6(3):219-29.

• Kukreja N, Onuma Y, Garcia-Garcia HM, Gaster AL, van Domburg R, Serruys PW. Long-term clinical outcome following percutaneous coronary intervention with bare or drug-eluting stents in unselected patients with multivessel disease. Am J Cardiol. 2009 Jan 15;103 (2):203-11.

• Kukreja N, Onuma Y, Daemen J, van Twisk P, Piazza N, van Domburg R, Serruys PW. Percutaneous coronary intervention for acute myocardial infarction: long-term outcome following bare metal and drug-eluting stent implantation in an unselected population. Circ Cardiovasc Interv. 2008 Oct;1(2):103-10.

• Daemen J, Kukreja N, van Twisk P, Onuma Y, de Jaegere PPT, van Domburg R, Serruys PW. Four-Year Clinical Follow-up of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry. Am J Cardiol. 2008 Apr 15; 101 (8):1105-11.

• Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and Late Coronary Stent Thrombosis of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Routine Clinical Practice: - Data from a Large Two-Institutional Cohort Study. Lancet. 2007 Feb 24; 369(9562): 667-78.

• Daemen J, Garcia-Garcia HM, Kukreja N, Imani F, de Jaegere PP, Sianos G, van Domburg RT, Serruys PW. The Long-term value of Sirolimus- and Paclitaxel-Eluting Stents as compared to bare metal stents in patients with diabetes mellitus. Eur Heart J. 2007 Jan; 28(1): 26-32.

Locations for cardiology treatment in Hertfordshire and North London

Contact details

Dr Neville Kukreja

Cardiac Suite L94
Lister Hospital
Corey's Mill Lane
Stevenage
Herts SG1 4AB

Secretary: 01438 781550
Mobile: 07800 543132

E-mail: info@hertfordshirecardiology.co.uk
Web: www.hertfordshirecardiology.co.uk

GMC registration details 

 Disclaimer

Intuition Communication Ltd bears no responsibility for information published on this website, which concerns or relates to advertisers and their products and services. Read Disclaimer in full.